×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
PR Newswire
Transitioning HBV cure programs into multiple late-stage combination studies with interim results throughout 2024 and 2025 informing...
1 month ago
Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate ...
PR Newswire
Acquiring all intellectual properties relating to BRII-179 and eliminating future milestone and royalty payments to VBI, subject to...
2 months ago
VBI Vaccines, Brii Biosciences expand Hepatitis B partnership
Pharmaceutical Technology
VBI Vaccines has announced the expansion of its HBV partnership with Brii Bio to address prevention and treatment of the disease.
10 months ago
Brii expands hepatitis B partnership with VBI in deal worth $437M
BioWorld MedTech
In a move to address both prevention and treatment of hepatitis B virus (HBV), Brii Biosciences Ltd. has acquired from VBI Vaccines Inc. a...
10 months ago
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer
PR Newswire
PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to...
4 months ago
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results USA - English - APAC - English
PR Newswire
First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several...
8 months ago
Brii Biosciences Closes US$155 Million Series C Financing
Business Wire
Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs...
37 months ago
The Biggest Asian Companies Caught in SVB's Fallout From SoftBank to Xero
Bloomberg.com
Silicon Valley Bank became the biggest US lender to fail in more than a decade, creating fears of contagion in tech and finance sectors in...
13 months ago
Brii Biosciences debuts in Hong Kong with $319M IPO, shares close 3.15% higher
BioWorld MedTech
Brii Biosciences Ltd. raised HK$2.482 billion (US$319 million) in its IPO in Hong Kong and will use the proceeds to support the development...
33 months ago
Brii Biosciences Provides Latest Clinical Development and Corporate Updates USA - English - APAC - English
PR Newswire
Company extends BRII-179 license to global rights and introduces preventive vaccine, PreHevbri® in Greater China and Asia Pacific markets...
10 months ago